| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 1200493-78-2 | (S)-N-(3-(2-amino-4-methyl-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide
| |
C18H14FN5OS | 367.4 |
| 877969-69-2 | (S)-N-(1-(3,4-Difluorophenyl)ethyl)-1H-indazole-3-carboxamide
VPC-80051 racemate | |
C16H13F2N3O | 301.29 |
| 887375-15-7 | (S)-Mapracorat
| |
C25H26F4N2O2 | 462.48 |
| 2055172-61-5 | (S)-KT109
| |
C27H26N4O | 422.5217 |
| 2166616-76-6 | (S)-IDO1-IN-5
| |
C23H25FN2O3 | 396.45 |
| 1189561-66-7 | (S)-Gossypol acetic acid((S)-(+)-Gossypol acetic acid)
| |
C32H34O10 | 578.61 |
| 2003234-64-6 | (S)-GNE-140
| |
C25H23ClN2O3S2 | 499.04 |
| 913844-45-8 | (S)-Glycyl-H-1152 hydrochloride
(S)-Glycyl-H-1152 hydrochloride (Rho Kinase Inhibitor IV) | |
C18H24N4O3S • 2HCl | 449.4 |
| 1435727-97-1 | (S)-Duloxetine D3 hydrochloride
Duloxetine D3 hydrochloride | |
C18H17D3ClNOS | 336.89 |
| 188398-87-0 | (S)-Desoxy-D2PM hydrochloride
(S)-Desoxy-D2PM hydrochloride ((S)-2-Diphenylmethylpyrrolidine) | |
C17H19N • HCl | 273.8 |
| 1352226-87-9 | (S)-Ceralasertib
| |
C20H24N6O2S | 412.51 |
| 2244989-34-0 | (S)-B-973B
| |
C24H26F2N6O | 452.51 |
| 135415-73-5 | (S)-7-乙基-7-羟基-7H-[1,3]二氧杂环戊烯并[4,5-g]吡喃并[3',4':6,7]吲哚并[1,2-b]喹啉-8,11(10H,13H)-二酮
(S)-7-Ethyl-7-hydroxy-7H-[1,3]dioxolo[4,5-g]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-8,11(10H,13H)-dione | |
C21H16N2O6 | 392.36 |
| 2413428-36-9 | (S)-5-苄基-18-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)-4,7,10,13-四氧代-3,6,9,12-四氮杂十八烷-1-酸
(S)-5-Benzyl-18-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctadecan-1-oic acid | |
C25H31N5O8 | 529.54 |
| 307297-39-8 | (S)-4-((S)-2-氨基丙酰胺基)-5-(((S)-3-羧基-1-((羧甲基)氨基)-1-氧代丙烷-2-基)氨基)-5-氧代戊酸
4-[(2-Amino-1-hydroxypropylidene)amino]-5-(3-carboxy-1-[(carboxymethyl)imino]-1-hydroxypropan-2-ylimino)-5-hydroxypentanoic acid | |
C14H22N4O9 | 390.35 |
| 2376257-44-0 | (S)-4-((2-甲氧基乙基)(4-(5,6,7,8-四氢-1,8-萘啶-2-基)丁基)氨基)-2-(喹唑啉-4-基氨基)丁酸
(S)-4-((2-Methoxyethyl)(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl)amino)-2-(quinazolin-4-ylamino)butanoic acid | |
C27H36N6O3 | 492.61 |
| 2068-83-9 | (S)-3-Hydroxyisobutyric acid
| |
C4H8O3 | 104.10 |
| 2097136-42-8 | (S)-3'-hydroxy Blebbistatin
| |
C18H16N2O3 | 308.33132 |
| 2097141-18-7 | (S)-3'-amino Blebbistatin
| |
C18H17N3O2 | 307.3466 |
| 138644-99-2 | (S)-3 '-羟基- N-甲基环锁骨酸盐酸盐
(S)-3’-Hydroxy-N-methylcoclaurine Hydrochloride | |
C18H22ClNO4 | 351.82458 |
| 1962925-29-6 | (S)-2-(((S)-6,8-二氟-1,2,3,4-四氢萘-2-基)氨基)-N-(1-(2-甲基-1-(新戊基氨基)丙-2-基)-1H-咪唑-4-基)戊酰胺 二氢溴酸盐
(S)-2-(((S)-6,8-Difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide dihydrobromide | |
C27H43Br2F2N5O | 651.47 |
| 328087-38-3 | (S)-2,6-二氨基-N-(4-(5-氟苯并[d]噻唑-2-基)-2-甲基苯基)己酰胺二盐酸盐
(S)-2,6-Diamino-N-(4-(5-fluorobenzo[d]thiazol-2-yl)-2-methylphenyl)hexanamide dihydrochloride | |
C20H25Cl2FN4OS | 459.41 |
| 142761-12-4 | (S)-(+)-O-去甲-文拉法辛
(S)-(+)-O-Desmethyl Venlafaxine | |
C16H25NO2 | 263.38 |
| 25390-17-4 | (RS)-羧甲司坦
(RS)-Carbocisteine (S-(Carboxymethyl)-DL-cysteine) | |
C5H9NO4S | 179.19 |
| 2320274-78-8 | (RS)-Butyryltimolol
| |
C17H30N4O4S | 386.51 |
| 107077-98-5 | (rel)-Tranylcypromine D5 hydrochloride
| |
C9H7D5ClN | 174.68 |
| 1672662-07-5 | (Rac)-PT2399
| |
C17H10F5NO4S | 419.32 |
| 2435557-99-4 | (Rac)-NMDAR antagonist 1
| |
C20H20BrN3O2 | 414.30 |
| 405225-21-0 | (Rac)-NFPS
(Rac)-ALX 5407 | |
C24H24FNO3 | 393.45 |
| 2166616-74-4 | (Rac)-IDO1-IN-5
| |
C23H25FN2O3 | 396.45 |
| 2070009-31-1 | (R,S)-Ivosidenib((R,S)-AG-120)
| |
C28H22ClF3N6O3 | 582.96 |
| 1786438-30-9 | (R)-CR8 trihydrochloride
| |
C24H32Cl3N7O | 540.92 |
| 1691249-44-1 | (R)-Zanubrutinib ((R)-BGB-3111)
| |
C27H29N5O3 | 471.55 |
| 2097818-14-7 | (R)-VU 6008667
| |
C24H17ClF2N2O2 | 438.85 |
| 1330782-69-8 | (R)-Simurosertib ((R)-TAK-931
| |
C17H19N5OS | 341.43 |
| 2252493-33-5 | (R)-ND-336
| |
C16H18ClNO3S2 | 371.90 |
| 2866179-95-3 | (R)-N-乙基-5-氟-N-异丙基-2-((5-(2-(6-((2-甲氧基乙基)(甲基)氨基)-2-甲基己-3-基)-2,6-二氮杂螺[3.4]辛烷-6-基)-1,2,4-三嗪-6-基)氧基) 苯甲酰胺 草酸盐
(R)-N-Ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)- 1,2,4-triazin-6-yl)oxy)benzamide oxalate | |
C34H52FN7O7 | 689.82 |
| 305335-29-9 | (R)-MLN-4760
| |
C19H23Cl2N3O4 | 428.31 |
| 2055172-60-4 | (R)-KT109
| |
C27H26N4O | 422.5217 |
| 121839-78-9 | (R)-Ibuprofenamide
(-)-Ibuprofenamide | |
C13H19NO | 205.3 |
| 1959551-27-9 | (R)-FT671
| |
C24H23F4N7O3 | 533.48 |
| 102676-87-9 | (R)-Fadrozole
| |
C14H13N3 | 223.27 |
| 215168-33-5 | (R)-Butaprost free acid
| |
C23H38O5 | 394.6 |
| 1415390-47-4 | (R)-BPO-27
| |
C26H18BrN3O6 | 548.34 |
| 1564269-85-7 | (R)-BAY1238097
| |
C25H33N5O3 | 451.56 |
| 851881-59-9 | (R)-ADX-47273
| |
C20H17F2N3O2 | 369.36 |
| 100761-20-4 | (R)-5-羟基-1,7-二苯基-3-庚酮
(5R)-5-Hydroxy-1,7-diphenyl-3-heptanone | |
C19H22O2 | 282.38 |
| 2553217-91-5 | (R)-5-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-1-fluorohexan-2-one
BSH-IN-1 | |
C25H41FO3 | 408.59 |
| 1253573-53-3 | (R)-4-(2-((5-氟-6-甲氧基吡啶-3-基)氨基)-5-(1-(4-(甲基磺酰基)哌嗪-1-基)乙基)吡啶-3-基)-6-甲基-1,3,5-三嗪-2-胺
(R)-4-(2-((5-Fluoro-6-methoxypyridin-3-yl)amino)-5-(1-(4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine | |
C22H28FN9O3S | 517.58 |
| 1423719-30-5 | (R)-2-(4-(5-氯嘧啶-2-基)哌啶-1-基)-4-((1-(羟甲基)环丁基)氨基)-6,7-二氢噻吩并[3,2-d]嘧啶 5-氧化物
(R)-2-(4-(5-Chloropyrimidin-2-yl)piperidin-1-yl)-4-((1-(hydroxymethyl)cyclobutyl)amino)-6,7-dihydrothieno[3,2-d]pyrimidine 5-oxide | |
C20H25ClN6O2S | 448.97 |
